NOKOMIS, Fla.--(BUSINESS WIRE)--Houston, Texas, the home base of Rainbow Coral Corp.’s (OTCBB:RBCC) biosciences division, is bursting with potential customers for n3D’s Bio-Assembler system. Just last month, the largest stem cell lab and bank in North America opened in Sugar Land, the city’s fastest-growing suburb.
Opened by Celltex Therapeutics, the 15,000 sq ft facility will grow and bank stem cells with the potential to be used in medical treatments. The lab is precisely the kind of potential Bio-Assembler customer that RBCC plans to target once its transaction with n3D is finalized.
“Celltex Therapeutics is only the latest biotech company to set up shop in the Houston area,” said RBCC CEO Patrick Brown. “The city leads the nation in National Institutes of Health funding. We’re hard at work building our local business network in order to hit the ground running in marketing the Bio-Assembler system once a deal with n3D is reached.”
Nano3D Biosciences’ Bio-Assembler system allows cell researchers to grow three-dimension cell clusters that more closely resemble those found in the body more easily and affordably than ever before. The breakthrough could have extremely positive ramifications for labs like the one in Sugar Land.
For more information on Rainbow BioSciences, Rainbow Coral’s biotech division, please visit www.rainbowbiosciences.com/investors.
Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Celgene Corp. (NASDAQ: CELG), Cardinal Health, Inc. (NYSE: CAH), Abbott Laboratories (NYSE: ABT) and Affymax, Inc. (NASDAQ: AFFY).
Follow us on Twitter at www.twitter.com/RBCCinfo.
About Rainbow BioSciences
Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.rainbowbiosciences.com]. For investment information and performance data on the company, please visit www.RainbowBioSciences.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.